Minerva Neurosciences (NERV) had the highest return between August 19, 2022 and September 27, 2022 by a US stock in the Nasdaq Composite (IXIC), returning 176.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Minerva Neurosciences (NERV) | 8/19/2022 - 9/27/2022 | 176.47% |
RDE (GIFT) | 8/19/2022 - 9/27/2022 | 142.42% |
Reviva Pharmaceuticals (RVPH) | 8/19/2022 - 9/27/2022 | 123.61% |
Akero Therapeutics (AKRO) | 8/19/2022 - 9/27/2022 | 118.8% |
Enliven Therapeutics (ELVN) | 8/19/2022 - 9/27/2022 | 97.32% |
Heartbeam (BEAT) | 8/19/2022 - 9/27/2022 | 94.93% |
Spero Therapeutics (SPRO) | 8/19/2022 - 9/27/2022 | 94.23% |
Cassava Sciences (SAVA) | 8/19/2022 - 9/27/2022 | 77.62% |
LAVA Therapeutics (LVTX) | 8/19/2022 - 9/27/2022 | 67.78% |
Lion (LGHL) | 8/19/2022 - 9/27/2022 | 59.09% |
Meihua International Medical Technologies (MHUA) | 8/19/2022 - 9/27/2022 | 58.59% |
Immuneering (IMRX) | 8/19/2022 - 9/27/2022 | 57.74% |
Ventyx Biosciences (VTYX) | 8/19/2022 - 9/27/2022 | 51.21% |
Jowell Global (JWEL) | 8/19/2022 - 9/27/2022 | 50.99% |
Hillevax (HLVX) | 8/19/2022 - 9/27/2022 | 48.18% |
Innovative Solutions and Support (ISSC) | 8/19/2022 - 9/27/2022 | 45.65% |
Belite Bio Inc ADR (BLTE) | 8/19/2022 - 9/27/2022 | 45.62% |
InnovAge (INNV) | 8/19/2022 - 9/27/2022 | 45.19% |
Stabilis Solutions (SLNG) | 8/19/2022 - 9/27/2022 | 43.4% |
NLS Pharmaceutics (NLSP) | 8/19/2022 - 9/27/2022 | 41.2% |
Huadi International (HUDI) | 8/19/2022 - 9/27/2022 | 40.77% |
Ideaya Biosciences (IDYA) | 8/19/2022 - 9/27/2022 | 34.01% |
OKYO Pharma Ltd ADR (OKYO) | 8/19/2022 - 9/27/2022 | 33.5% |
Sono-Tek (SOTK) | 8/19/2022 - 9/27/2022 | 33.27% |
PDD (PDD) | 8/19/2022 - 9/27/2022 | 31.39% |
